JPRN-UMIN000018200
Recruiting
未知
A randomised contorl study comparing the safety of cold snare polypectomy in patients with colorectal polyp below 10 mm at high versus low risk of bleeding - A study comparing the safety of CSP on warfarin v.s. warfarin plus antiplatelet agents
ational Hospital Organization Kyushu Medical Center0 sites180 target enrollmentJuly 7, 2015
ConditionsColorectal polyp
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Colorectal polyp
- Sponsor
- ational Hospital Organization Kyushu Medical Center
- Enrollment
- 180
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)polyps \>10mm 2\)Patients with severe comorbidity 3\)Patients during pregnancy 4\)bleeding tendency except for a drug 5\)others
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
A randomised comparison of safety and efficacy of triple therapy for 12 weeks, followed by 12 or 36 additional weeks of peginterferon alfa 2b and ribavirin in HCV patientsJPRN-UMIN000006952Hiroshima liver study group230
Not yet recruiting
Not Applicable
Safety of sedation with and without prophylactic placement of nasopharyngeal airway in children during MRICTRI/2022/01/039483Rainbow Childrens Hospital
Recruiting
Not Applicable
A study to check if C-Reactive Protein is needed before stopping antibiotics in newborn babies suspected to have bacterial infection whose blood cultures are negativeCTRI/2020/05/025440CMC hospital Vellore
Recruiting
Phase 1
Randomized trial comparing efficacy and safety of initial triple therapy including parenteral treprostinil to initial double oral therapy in PAH group I patients – TripleTREPulmonary arterial hypertension (group I)MedDRA version: 21.1Level: PTClassification code: 10064911Term: Pulmonary arterial hypertension Class: 100000004855Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]CTIS2023-504351-26-01Aop Orphan Pharmaceuticals GmbH117
Active, not recruiting
Phase 1
Evaluate the safety and efficacy of IPX203 carbidopa-levodopa extended release capsules compared to carbidopa-levodopa immediate release tablets in patients with Parkinson's with motor fluctuations.Parkinson's diseaseMedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: PTClassification code 10028035Term: Movement disorderSystem Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2018-002233-37-ITImpax Laboratories, LLC510